HOLLYWOOD, Calif., Dec. 5, 2012 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), responded to a landmark ruling issued by an Arizona state court yesterday that sent positive reinforcement throughout the medical marijuana industry in Arizona and the nation.
Medbox played a key role during the Arizona dispensary lottery system and helped its consulting clients obtain 20 of the 97 total licenses granted by the Arizona Department of Health Services. The 2-year process was fraught with legal challenges and pitfalls that Medbox properly navigated on behalf of its clients. The licenses were awarded to those clients on August 7, 2012, giving Medbox receivables due on that day of over $1.3 million dollars. However, industry opponents were challenging the legality of the law for a second time, as the first was struck down by a federal judge in early 2012, prompting the dispensary licensing program to commence after a year long pause. This time around, according to Associated Press, a state court judge ruled that Arizona's medical marijuana law is constitutional and federal drug laws don't stand in the way of public officials implementing the state law.
"This court will not rule that Arizona, having sided with the ever-growing minority of states and having limited it to medical use, has violated public policy," Judge Michael Gordon of Maricopa County Superior Court wrote.
Company CEO, Dr. Bruce Bedrick commented, "The decision is a game changer as it sets a clear tone that the will of the voters needs to be honored on the state level regardless of political agendas that may be work to undermine a true democracy."
On a positive note for the company, according to its officers, it can now collect on the $1.3 million dollars it had generated in receivables revenue based on consulting client successes in Arizona on the license approval day of August 7, 2012. The company had ceased all collection efforts from its Arizona clients until the litigation had concluded with a positive outcome.
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.
Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.
Medbox, Inc. is a publicly traded company, and its common stock is quoted on the OTC Markets, ticker symbol MDBX.
For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.
SOURCE Medbox, Inc.